Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The mycobacterial membrane lipid bilayer is a fundamental structural component of the mycobacterial cell envelope, distinguished by its exceptional complexity and high lipid content (Brennan & Nikaido, 1995). It consists of an inner cytoplasmic membrane and a unique outer membrane, known as the mycomembrane, which is primarily composed of long-chain mycolic acids (Dulberger et al., 2020). This lipid-rich architecture functions as a highly effective permeability barrier, shielding the bacterium from host immune responses and limiting the entry of many conventional antibiotics (Minnikin, 1982). In the context of disease, this barrier is a primary reason for the intrinsic drug resistance observed in Mycobacterium tuberculosis and other mycobacterial pathogens (Dulberger et al., 2020). Therapeutic strategies often target the membrane by inhibiting the biosynthesis of its lipid constituents, such as mycolic acids, or by directly disrupting membrane integrity and the proton motive force (Zhang et al., 2003). Additionally, membrane-bound proteins like ATP synthase are the targets of modern antitubercular drugs like bedaquiline (Andries et al., 2005). Understanding the complex architecture of this lipid bilayer is crucial for developing new treatments against drug-resistant mycobacterial strains.
Inhibition of mycolic acid biosynthesis, disruption of the proton motive force and membrane potential, inhibition of membrane-bound ATP synthase, and disruption of membrane physical integrity.
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Mycobacterial membrane lipid bilayer.